You have no items in your shopping cart.
Description
Research Area
Immunology & Inflammation
Images & Validation
−
| Application Notes |
|---|
Key Properties
−| Source | Sf9, Baculovirus cells |
|---|---|
| Purity | Greater than 95.0% as determined by SDS-PAGE. |
| Protein Sequence | SGPVKELVGS VGGAVTFPLK SKVKQVDSIV WTFNTTPLVT IQPEGGTIIV TQNRNRERVD FPDGGYSLKL SKLKKNDSGI YYVGIYSSSL QQPSTQEYVL HVYEHLSKPK VTMGLQSNKN GTCVTNLTCC MEHGEEDVIY TWKALGQAAN ESHNGSILPI SWRWGESDMT FICVARNPVS RNFSSPILAR KLCEGAADDP DSSMLEHHHH HH |
Storage & Handling
−| Storage | Stability: Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles |
|---|---|
| Form/Appearance | Sterile Filtered clear solution. |
| Buffer/Preservatives | SLAMF7 protein solution (0.5mg/ml) contains Phosphate Buffered Saline (pH 7.4) and 10% glycerol. |
| Expiration Date | 6 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−SLAMF7, SLAM Family Member 7, CD2-Like Receptor-Activating Cytotoxic Cells, Membrane Protein FOAP-12, CD2 Subset 1, Protein 19A, CRACC, CS1, Novel LY9 (Lymphocyte Antigen 9) Like Protein, CD2-Like Receptor Activating Cytotoxic Cells, 19A24 Protein, CD319 Antigen, Novel Ly9, CD319, 19A.
Similar Products
−- Item 1 of 1
Human Signaling Lymphocytic Activation Molecule Family, Member 7 (SLAMF7) ELISA Kit [orb777772]
Human
0.16-10 ng/mL
0.054 ng/mL
48 T, 96 T Recombinant Human SLAMF7 Protein [orb2995149]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 23.4 KDa. Observed: 32-50 KDa, reducing conditions
10 μg, 500 μg, 1 mg, 50 μgRecombinant Human SLAMF7 Protein (Biotin) [orb2993689]
Biotin
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 25.2 KDa. Observed: 35-55 KDa, reducing conditions
20 μg, 100 μgRecombinant Human SLAMF7 Protein [orb2993764]
Unconjugated
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE.
Predicted: 49 KDa. Observed: 60-90 KDa, reducing conditions
50 μg, 500 μg, 1 mg, 10 μg- Item 1 of 4
Recombinant Human SLAM family member 7 (SLAMF7), partial (Active) [orb3155644]
Greater than 95% as determined by SDS-PAGE.
23.8 kDa
Mammalian cell
1 mg, 100 μg, 20 μg
Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.
Protocol Information
Protein Handling and Storage Guide
Protein Handling Guide
Available Sizes
Select a size below
Usually dispatched within 5-10 working days